Abdelaziz M. Elhaddad
Expertise in
104
conditions

Dr. Abdelaziz M. Elhaddad

Hematology Oncology
411 Laurel St., Suite A300, 
Des Moines, IA 
Accepting New Patients
Expertise in
104
conditions
411 Laurel St., Suite A300, 
Des Moines, IA 

Overview

"""Abdelaziz ElHaddad, MD is a medical oncology and hematology Physician with Mission Cancer + Blood.He is board certified in Internal Medicine, Hematology and Medical Oncology as well. After graduating with Honors from Cairo University Faculty of Medicine in the top 25th percentile of his class, he went on to finish his Internal Medicine training at Monmouth Medical Center, a Drexel University affiliated hospital in New Jersey. He subsequently completed his medical oncology and hematology fellowship training at Mount Sinai School of Medicine, St. Luke’s Roosevelt hospital in New York City.""".

Dr. Elhaddad is highly rated in 104 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Essential Thrombocythemia, Thrombocytopenia, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles. Dr. Elhaddad is currently accepting new patients.

Specialties

Hematology Oncology

Licenses

Internal Medicine in IA

Hospital Affiliations

University Of Iowa Hospital & Clinics
Unitypoint Health - Des Moines Iowa Methodist Medi
Madison County Health Care System
Mercyone Des Moines Medical Center
Knoxville Hospital & Clinics

Languages Spoken

English
Arabic

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Associates
  • MEDICARE MAPD
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 17 Less Insurance Carriers -

Locations

Mission Blood + Cancer
411 Laurel St., Suite A300, Des Moines, IA 50314

Additional Areas of Focus

Dr. Elhaddad has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Total Publications

Rapidly enlarging malignant abdominal PEComa with hepatic metastasis: a promising initial response to sirolimus following surgical excision of primary tumor.
Rapidly enlarging malignant abdominal PEComa with hepatic metastasis: a promising initial response to sirolimus following surgical excision of primary tumor.
Journal: Oxford medical case reports
Published: December 20, 2019
Similar Doctors
Expertise in
89
conditions
Dr. Robert J. Behrens
Hematology Oncology
Expertise in
89
conditions
Dr. Robert J. Behrens
Hematology Oncology
Referral may be required

Mission Blood + Cancer

411 Laurel St., Suite A300, 
Des Moines, IA 
 (0.1 miles away)
515-247-3970
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Beherns, MD is a medical oncology and hematology physician with Mission Cancer + Blood. Dr. Behrens received a Bachelor of Science degree with distinction in Chemistry from Iowa State University. His medical degree was awarded by the University of Iowa College of Medicine. He completed a residency in Internal Medicine at the Johns Hopkins University / Sinai Hospital in Baltimore, Maryland. Dr. Behrens completed a fellowship at the National Cancer Institute (NCI) in Bethesda, Maryland. He specialized in immuno-therapy of cancer and was protocol chairman of a national breast cancer vaccine trial. Dr. Behrens has been extensively involved in colon, pancreas, and ovarian vaccine trials. Dr. Behrens is highly rated in 89 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Febrile Neutropenia, Agranulocytosis, Bone Marrow Aspiration, and Colonoscopy. Dr. Behrens is currently accepting new patients.

Expertise in
104
conditions
Dr. Thomas R. Buroker
Hematology Oncology
Expertise in
104
conditions
Dr. Thomas R. Buroker
Hematology Oncology
Referral may be required

Mission Blood + Cancer

411 Laurel St., Suite A300, 
Des Moines, IA 
 (0.1 miles away)
515-247-3970
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dr. Thomas Buroker completed his undergraduate work at The University of Iowa where he graduated in 1964. He went on to graduate from the College of Osteopathy Medical and Surgery (now the Des Moines University). Dr. Buroker completed a residency at the Grace Hospital in Detroit. He completed a fellowship in Medical Oncology at Wayne State University Medical School in Detroit. Dr. Buroker is highly rated in 104 conditions, according to our data. His clinical expertise encompasses Severe Congenital Neutropenia, Lung Cancer, Pleuropulmonary Blastoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Buroker is currently accepting new patients.

Expertise in
73
conditions
Dr. Daniel M. Buroker
Hematology Oncology
Expertise in
73
conditions
Dr. Daniel M. Buroker
Hematology Oncology
Referral may be required

Mission Blood + Cancer

411 Laurel St., Suite A300, 
Des Moines, IA 
 (0.1 miles away)
515-247-3970
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dr. Daniel Buroker is a medical oncologist. He earned his medical degree from the University of Iowa. After medical school, Dr. Buroker completed his residency at the Iowa Methodist Medical Center in Des Moines. Dr. Buroker is highly rated in 73 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, Bone Marrow Aspiration, and Gastrostomy. Dr. Buroker is currently accepting new patients.

Frequently Asked Questions about Dr. Abdelaziz M. Elhaddad

How do I make an appointment with Dr. Abdelaziz M. Elhaddad?

You can book an appointment with Dr. Abdelaziz M. Elhaddad by calling their office at 515-247-3970. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Abdelaziz M. Elhaddad a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Abdelaziz M. Elhaddad is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Abdelaziz M. Elhaddad specialize in?

While Dr. Abdelaziz M. Elhaddad is a Hematology Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Essential Thrombocythemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Abdelaziz M. Elhaddad participate in research or clinical trials?

Yes. Dr. Abdelaziz M. Elhaddad has published 2 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Abdelaziz M. Elhaddad's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Abdelaziz M. Elhaddad accept my insurance?

Dr. Abdelaziz M. Elhaddad accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 515-247-3970 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Elhaddad's expertise for a condition
ConditionClose
    View All 13 Distinguished Conditions
    View All 91 Advanced Conditions
    View All 139 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile